Loading insider details...
Latest Form 4 (Jun 17, 2026): Grant/Award of 31,000 ENGN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 17, 2026 | enGene Therapeutics Inc. (ENGN) | Grant/Award | 31,000 | n/a |
| Oct 15, 2025 | ESSA Pharma Inc. (EPIX) | Disposition to Issuer | 43,240 | n/a |
| Jun 16, 2025 | enGene Holdings Inc. (ENGN) | Grant/Award | 22,500 | n/a |
| Jun 18, 2024 | enGene Holdings Inc. (ENGN) | Grant/Award | 20,000 | n/a |
| May 29, 2024 | enGene Holdings Inc. (ENGN) | Exercise/Conversion | 120 | $106.80 |
| Apr 25, 2024 | ESSA Pharma Inc. (EPIX) | Exercise/Conversion | 3,750 | $18.4K |
| Mar 28, 2024 | ESSA Pharma Inc. (EPIX) | Grant/Award | 70,000 | n/a |
| Nov 2, 2023 | enGene Holdings Inc. (ENGN) | Grant/Award | 24,555 | n/a |
| Nov 1, 2022 | ESSA Pharma Inc. (EPIX) | Grant/Award | 35,000 | n/a |
| Jan 11, 2021 | ESSA Pharma Inc. (EPIX) | Grant/Award | 25,000 | n/a |